NCT07210892 Paramedian Incidence Angles in Spinal Anaesthesia
| NCT ID | NCT07210892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Consorci Sanitari de Terrassa |
| Condition | Anesthesia; Adverse Effect, Spinal and Epidural |
| Study Type | OBSERVATIONAL |
| Enrollment | 90 participants |
| Start Date | 2025-09-30 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 90 participants in total. It began in 2025-09-30 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective here is to quantify the number of punctures and redirections during routine practice in the anesthesiology department, verify the final angle of incidence and the sac-skin distance by ultrasound, and determine the optimal, maximum, and minimum angles that would have allowed successful punctures. The objective is also to correlate ultrasound and plain X-ray distances, if available. These angles would then be inferred in advance in patients who must undergo spinal anesthesia, assessing whether this prior estimate reduces the number of punctures and redirections.
Eligibility Criteria
Inclusion Criteria: patients submitted to spinal anaesthesia - Exclusion Criteria: none \-
Contact & Investigator
Alberto Prats-Galino, M.D., Ph.D
PRINCIPAL INVESTIGATOR
University of Barcelona
Frequently Asked Questions
Who can join the NCT07210892 clinical trial?
This trial is open to participants of all sexes, studying Anesthesia; Adverse Effect, Spinal and Epidural. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07210892 currently recruiting?
Yes, NCT07210892 is actively recruiting participants. Contact the research team at apuigdellivol@ub.edu for enrollment information.
Where is the NCT07210892 trial being conducted?
This trial is being conducted at Barcelona, Spain.
Who is sponsoring the NCT07210892 clinical trial?
NCT07210892 is sponsored by Consorci Sanitari de Terrassa. The principal investigator is Alberto Prats-Galino, M.D., Ph.D at University of Barcelona. The trial plans to enroll 90 participants.